CULVER CITY, Calif., Sept. 27, 2001 (PRIMEZONE) -- CARESIDE, Inc. (AMEX:CSA), a provider of point-of-care blood analysis instrumentation and records management, announced today that it has promoted veteran sales executive David R. Crais, 37, to Vice President of Sales, effective immediately. In this role, Crais will be responsible for directing both domestic and international sales activities, formulating sales strategies, coordinating sales programs and overseeing Careside's sales team.
Careside Chairman and Chief Executive Officer W. Vickery Stoughton commented, "As we shift to a complete marketing focus, it is important we have strong leadership in sales and marketing. David has continuously demonstrated strategic thinking and marketplace knowledge for point-of-care testing. He has the respect of all of the Sales Representatives and the entire Careside organization. He has demonstrated his abilities in sales management coupled with a track record of closing sales. We are pleased to have him as a senior member of this organization playing a critical role in our efforts to gain market acceptance of our products."
Crais joined Careside in 1999 as a Regional Sales Manager based in Chicago where he was responsible for sales in the Midwest. Subsequently, he was promoted to National Sales Director. Prior to joining Careside, Crais spent seven years as Strategic Sales Representative for Princeton, NJ-based I-STAT Corporation (Nasdaq:STAT), a maker of hand held point-of-care testing technology. During his tenure at I-STAT, Crais was the top sales representative for hospital contract sales in 1998.
Crais also has experience in international sales as he started an import/export brokerage and market consulting company, which he left in 1993. Crais has been a gubernatorial appointee for the State of Louisiana Imports and Exports Trust Authority, Gulf States Campaign Manager for Senator Paul Tsongas' Presidential race in 1992, and a Board Member of the Visiting Nurse Association in New Orleans.
He has a combined BA/BS degree from Loyola University, New Orleans, LA, and has done graduate studies at Universidad Iberoamericana in Mexico City.
About Careside, Inc.
CARESIDE, Inc. markets a proprietary blood testing system including its CARESIDE Analyzer, a companion hematology system called the H-2000 Hematology Analyzer, and its CARESIDE Connect record management system linking the two devices into customers' laboratory or patient information systems. The CARESIDE Analyzer provides a cost-effective and efficient means of measuring blood chemistry, electrochemistry, and coagulation function at the patient's point-of-care by producing accurate test results within 15 minutes. CARESIDE, Inc. is one of the world's leading developers of advanced point-of-care blood testing technology. For more information on the Company, call (888) 698-2273 or access www.careside.com.
Safe Harbor: Statements in this press release regarding CARESIDE Inc. which are not historical facts are forward-looking statements that involve risks and uncertainties. Key factors which may impact these statements include challenges inherent in product research, development, manufacturing and marketing, and the other factors discussed in the Company's prospectus filed October 2000. All such factors could cause actual results to differ materially from those presented in or suggested by such forward-looking statements. The Company undertakes no obligation to update forward-looking statements. Please see the risk factors listed from time to time in the Company's prospectus and reports on file with the Securities Exchange Commission.